Changes in dispensing of medicines proposed for re-purposing in the first year of the COVID-19 pandemic in Australia.
Andrea L SchafferDavid A HenryHelga ZoegaJulian H ElliottSallie-Anne PearsonPublished in: PloS one (2022)
While most increases in dispensing observed early on during COVID-19 were temporary and appear to be related to stockpiling among existing users, we observed increases in the initiation of hydroxychloroquine and ivermectin and a shift in prescribing patterns which may be related to the media hype around these medicines. A quick response by regulators can help limit inappropriate repurposing to lessen the impact on medicine supply and patient harm.